Summary
Global
Markets Direct's, 'Mitogen Activated Protein Kinase 1 (MAP Kinase 1 or MAPK 1
or Extracellular Signal Regulated Kinase 2 or ERK-2 or Protein Tyrosine Kinase
ERK2 or EC 2.7.11.24) - Pipeline Review, H1 2016', provides in depth analysis
on Mitogen Activated Protein Kinase 1 (MAP Kinase 1 or MAPK 1 or Extracellular
Signal Regulated Kinase 2 or ERK-2 or Protein Tyrosine Kinase ERK2 or EC
2.7.11.24) targeted pipeline therapeutics.
The
report provides comprehensive information on the Mitogen Activated Protein
Kinase 1 (MAP Kinase 1 or MAPK 1 or Extracellular Signal Regulated Kinase 2 or
ERK-2 or Protein Tyrosine Kinase ERK2 or EC 2.7.11.24), targeted therapeutics,
complete with analysis by indications, stage of development, mechanism of
action (MoA), route of administration (RoA) and molecule type. The report also
covers the descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved in
Mitogen Activated Protein Kinase 1 (MAP Kinase 1 or MAPK 1 or Extracellular
Signal Regulated Kinase 2 or ERK-2 or Protein Tyrosine Kinase ERK2 or EC
2.7.11.24) targeted therapeutics development and features dormant and discontinued
projects.
View Summary of
This Report @ http://www.radiantinsights.com/research/mitogen-activated-protein-kinase-1
Global
Markets Direct's report features investigational drugs from across globe
covering over 20 therapy areas and nearly 3,000 indications. The report is
built using data and information sourced from Global Markets Direct's
proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases
from company/university sites and industry-specific third party sources. Drug
profiles featured in the report undergoes periodic review following a stringent
set of processes to ensure that all the profiles are updated with the latest
set of information. Additionally, various dynamic tracking processes ensure
that the most recent developments are captured on a real time basis.
No comments:
Post a Comment